Philip Liang, Director at Vicarious Surgical Inc. (RBOT), bought 1,200 shares at $3.02 ($4K) on 2023-02-14, disclosed to the SEC on 2023-02-16.
Open-market purchase of $4k RBOT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| RBOT | BUY | 2023-04-11 | $13K | — | Filing → |
| RBOT | BUY | 2023-04-10 | $6K | — | Filing → |
| RBOT | BUY | 2023-03-30 | $172K | — | Filing → |